Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 10;12(1):293.
doi: 10.1186/s13071-019-3549-x.

Clearance dynamics of lactate dehydrogenase and aldolase following antimalarial treatment for Plasmodium falciparum infection

Affiliations

Clearance dynamics of lactate dehydrogenase and aldolase following antimalarial treatment for Plasmodium falciparum infection

Mateusz M Plucinski et al. Parasit Vectors. .

Abstract

Background: Lingering post-treatment parasite antigen in blood complicates malaria diagnosis through antigen detection. Characterization of antigen clearance dynamics is important for interpretation of positive antigen detection tests.

Results: We used a bead-based serological assay to measure lactate dehydrogenase (LDH), aldolase (Aldo), and histidine-rich protein 2 (HRP2) levels in 196 children with Plasmodium falciparum malaria treated with effective antimalarials and followed for 28 to 42 days as part of therapeutic efficacy studies in Angola. Compared to pre-treatment levels, antigen concentrations two days after treatment declined by 99.7% for LDH, 96.3% for Aldo, and 54.6% for HRP2. After Day 2, assuming a first-order kinetics clearance model, half-lives of the antigens were 1.8 days (95% CI: 1.5-2.3) for LDH, 3.2 days (95% CI: 3.0-3.4) for Aldo, and 4.8 days (95% CI: 4.7-4.9) for HRP2.

Conclusions: LDH and Aldo show substantially different clearance rates than HRP2, and their presence is largely indicative of active infection.

Keywords: Antigen; HRP2; Malaria; Rapid diagnostic test.

PubMed Disclaimer

Conflict of interest statement

The authors declare they do not have any commercial or other associations that might pose a competing interests.

Figures

Fig. 1
Fig. 1
Decline in absolute malaria antigen following antimalarial treatment in Angolan children with uncomplicated P. falciparum infection. Dashed red line represents the limit of detection for each antigen
Fig. 2
Fig. 2
Persistence of malaria antigens following antimalarial treatment in Angolan children with uncomplicated P. falciparum infection. Dashed lines represent confidence intervals of the survival function

References

    1. WHO . Malaria rapid diagnostic test performance: results of WHO product testing of malaria RDTs: round 7 (2015–2016) Geneva: World Health Organization; 2017.
    1. Chiodini PL. Malaria diagnostics: now and the future. Parasitology. 2014;141:1873–1879. doi: 10.1017/S0031182014001371. - DOI - PubMed
    1. Plucinski MM, Dimbu PR, Fortes F, Abdulla S, Ahmed S, Gutman J, et al. Post-treatment HRP2 clearance in patients with uncomplicated Plasmodium falciparum malaria. J Infect Dis. 2018;217:685–692. doi: 10.1093/infdis/jix622. - DOI - PMC - PubMed
    1. Dondorp AM, Desakorn V, Pongtavornpinyo W, Sahassananda D, Silamut K, Chotivanich K, et al. Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med. 2005;2:e204. doi: 10.1371/journal.pmed.0020204. - DOI - PMC - PubMed
    1. Bell DR, Wilson DW, Martin LB. False-positive results of a Plasmodium falciparum histidine-rich protein 2-detecting malaria rapid diagnostic test due to high sensitivity in a community with fluctuating low parasite density. Am J Trop Med Hyg. 2005;73:199–203. doi: 10.4269/ajtmh.2005.73.199. - DOI - PubMed

LinkOut - more resources